The Lancet

Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind ...

aResearch and Early Development, Novo Nordisk A/S, Måløv, Denmark bDevelopment, Novo Nordisk A/S, Søborg, Denmark ...
archive

Higher Mathematics In Problems And Exercises - Part 1

remove-circle Internet Archive's in-browser bookreader "theater" requires JavaScript to be enabled. It appears your browser does not have it turned on. Please see ...
C&EN

Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable ...

Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States ...
The Lancet

Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial

dDivision of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, NY, USA eDivision of Gastroenterology, Hepatology and Endoscopy, Brigham & Women's Hospital, Boston, MA, USA ...